![Zahra M, PharmD, MBA, BCOP, FHOPA Profile](https://pbs.twimg.com/profile_images/1724245975735123968/kKL_Yi8K_x96.jpg)
Zahra M, PharmD, MBA, BCOP, FHOPA
@kczmj
Followers
1K
Following
6K
Statuses
2K
Hematology/Cellular Therapies Pharmacy Manager @KUHospital |former PGY2 Oncology RPD @KUCancercenter| @HOPARx Secretary Board of Directors |Views= My Own
Joined October 2014
Bispecific antibodies are changing treatment in Hem/Onc.. but adoption has been mixed due to logistics! Out now in @JADPRO, we aim to tackle some FAQ! 🙏🏻 to @amirsali101 @thisisJamesD @SandahlTyler @VictoriaNachar @KPsiBCOP! #oncopharm #TwitterRx
2
12
46
RT @BloodAdvances: Receiving CAR T-cells gets faster, but not for all in need #InsideBloodAdvances #IBAs #clinicalt…
0
7
0
@bmtdoc63 @HOPArx @kamakshi_rao @shannonmhough @amyhseung @lakenned93 Thank you @bmtdoc63! And I, you!! 🤩see you at Tandem??
0
0
0
RT @lymphomahub: 📝 Results from the TRIANGLE trial presented by Martin Dreyling at #ASH24 found that ibrutinib-containing treatment without…
0
7
0
RT @RahulBanerjeeMD: Great to see in @JCOOP_ASCO - Mayo experience with outpt teclistamab step-up dosing in #MMsm. This is where the fiel…
0
15
0
RT @DSenFloor: PASSED: H.R.3391, Gabriella Miller Kids First Research Act 2.0 By unanimous consent.
0
356
0
RT @AhmedKo45911157: 👌Excellent algorithm 🔍 First-line AML Treatment Simplified 📊 💡 Intensive vs Non-Intensive Chemotherapy 🔑 Highlights: ✅…
0
19
0
RT @ChenyuLinMD: First MSC approval by @FDAOncology for steroid-refractory acute #GVHD in pediatric patients! Fascinating and promising tec…
0
3
0
RT @KUcancercenter: Register today for the 2025 KU ASH Review: Current Updates in Hematologic Diseases, which will be held on Saturday, Jan…
0
1
0
RT @saraleidy_: Amazing experience donating stem cells today! For patients with blood cancer and blood disorders requiring transplant, unr…
0
9
0
RT @AhmedKo45911157: Long-term survivors of CAR T-cell therapy face unique late complications: 📉 Cytopenias 🛡️ Infections 🧪 Hypogammaglobul…
0
13
0